Drawing for LUNDEYNA

USPTO serial 79167964

LUNDEYNA

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
KHOURI, SANI PHILIPPE
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUNDEYNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, leukemia, metastasis, autoimmune disease, rheumatoid arthritis, allergy, bacterial infection, viral infection, fungal infection, inflammation, sepsis, spinal cord injury, musculoskeletal disorders, pain, central nervous system disease, neurological disease, mood disorders, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease, constipation; vaccines; diagnostic reagents and contrast media for medical useABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 10, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
May 17, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 28, 2017FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 28, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 28, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 28, 2016MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Mar 28, 2016ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 28, 2016OP.TOPPOSITION TERMINATED NO. 999999—
Mar 28, 2016OP.DOPPOSITION DISMISSED NO. 999999—
Jan 4, 2016RFNPREFUSAL PROCESSED BY IB—
Dec 22, 2015OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 17, 2015OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Dec 17, 2015OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Dec 1, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 1, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 28, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 18, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 29, 2015NPUBNOTICE OF PUBLICATION—
Jul 14, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 13, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 8, 2015DOCKASSIGNED TO EXAMINER—
Jul 8, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 7, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 2, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance